Full Text View
Tabular View
Study Results
Related Studies
Safety and Efficacy of Oral Midazolam for Perioperative Anxiety Relief of Patients Undergoing Mohs Micrographic Surgery
This study has been completed.
Study NCT00578214   Information provided by Mayo Clinic

First Received on December 20, 2007.   Last Updated on February 8, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Basal Cell Carcinoma
Squamous Cell Carcinoma
Skin Cancer
Anxiety
Additional conditions recognized in this trial
Anxiety Disorders
Carcinoma
Carcinoma, Basal Cell
Carcinoma, Squamous Cell
Skin Neoplasms
More general conditions related to this trial
Mental Disorders
Neoplasms
Neoplasms by Histologic Type
Neoplasms by Site
Neoplasms, Basal Cell
Neoplasms, Glandular and Epithelial
Neoplasms, Squamous Cell
Skin Diseases
Interventions listed in this trial
Randomized Midazolam
Placebo
Local Anesthesia
Prospective Midazolam
Additional drug interventions recognized in this trial
Anesthetics
Midazolam
More general drug interventions related to this trial
Adjuvants, Anesthesia
Anesthetics, General
Anesthetics, Intravenous
Anti-Anxiety Agents
Central Nervous System Agents
Central Nervous System Depressants
GABA Agents
GABA Modulators
Hypnotics and Sedatives
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Pharmacologic Actions
Physiological Effects of Drugs
Psychotropic Drugs
Therapeutic Uses
Tranquilizing Agents
Sponsors listed in this trial
Mayo Clinic


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services